CN106589424B - 一种注射用交联透明质酸凝胶及其制备方法 - Google Patents
一种注射用交联透明质酸凝胶及其制备方法 Download PDFInfo
- Publication number
- CN106589424B CN106589424B CN201611138968.6A CN201611138968A CN106589424B CN 106589424 B CN106589424 B CN 106589424B CN 201611138968 A CN201611138968 A CN 201611138968A CN 106589424 B CN106589424 B CN 106589424B
- Authority
- CN
- China
- Prior art keywords
- hyaluronic acid
- gel
- cross
- crosslinking
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920002674 hyaluronan Polymers 0.000 title claims abstract description 112
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims abstract description 110
- 229960003160 hyaluronic acid Drugs 0.000 title claims abstract description 110
- 238000002347 injection Methods 0.000 title claims abstract description 36
- 239000007924 injection Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title abstract description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 81
- 238000004132 cross linking Methods 0.000 claims abstract description 63
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 48
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 230000007935 neutral effect Effects 0.000 claims abstract description 13
- 239000000243 solution Substances 0.000 claims abstract description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 21
- 229920001223 polyethylene glycol Polymers 0.000 claims description 21
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 claims description 15
- 150000002118 epoxides Chemical class 0.000 claims description 2
- 239000003589 local anesthetic agent Substances 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims 1
- 238000000502 dialysis Methods 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000011049 filling Methods 0.000 abstract description 17
- 238000006073 displacement reaction Methods 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 4
- 206010033675 panniculitis Diseases 0.000 abstract description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 99
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 7
- 239000008055 phosphate buffer solution Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000004872 soft tissue Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 3
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003416 augmentation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- -1 2- (vinylsulfonyl) ethoxy groups Chemical group 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/244—Stepwise homogeneous crosslinking of one polymer with one crosslinking system, e.g. partial curing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
凝胶编号 | 两份透明质酸配比 |
1-2 | 3:1 |
1-3 | 1:1 |
1-4 | 1:3 |
1-5 | 1:5 |
凝胶编号 | 交联温度 | 凝胶1交联时间 | 两份凝胶合并后交联时间 |
2-2 | 20℃ | 90min | 6h |
2-3 | 20℃ | 60min | 12h |
2-4 | 20℃ | 90min | 12h |
2-5 | 40℃ | 60min | 3h |
2-6 | 40℃ | 60min | 3h |
2-7 | 40℃ | 30min | 6h |
2-8 | 40℃ | 60min | 6h |
2-9 | 60℃ | 30min | 2h |
2-10 | 60℃ | 60min | 2h |
2-11 | 60℃ | 30min | 4h |
2-12 | 60℃ | 60min | 4h |
凝胶编号 | 凝胶1中交联剂用量 | 第二份凝胶中交联剂用量 |
3-1 | 2% | 2% |
3-2 | 2% | 8% |
3-3 | 2% | 15% |
3-4 | 8% | 2% |
3-5 | 8% | 8% |
3-6 | 8% | 15% |
3-7 | 15% | 2% |
3-8 | 15% | 8% |
3-9 | 15% | 15% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611138968.6A CN106589424B (zh) | 2016-12-12 | 2016-12-12 | 一种注射用交联透明质酸凝胶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611138968.6A CN106589424B (zh) | 2016-12-12 | 2016-12-12 | 一种注射用交联透明质酸凝胶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106589424A CN106589424A (zh) | 2017-04-26 |
CN106589424B true CN106589424B (zh) | 2020-06-02 |
Family
ID=58597517
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611138968.6A Active CN106589424B (zh) | 2016-12-12 | 2016-12-12 | 一种注射用交联透明质酸凝胶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106589424B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019001472A1 (zh) * | 2017-06-28 | 2019-01-03 | 北京键凯科技股份有限公司 | 分枝型多元甘醇环氧衍生物交联透明质酸钠凝胶及其制备和应用 |
CN109096483B (zh) * | 2017-06-28 | 2020-09-04 | 北京键凯科技股份有限公司 | 分枝型多元甘醇环氧衍生物交联透明质酸钠凝胶及其制备和应用 |
CN107793577A (zh) * | 2017-11-29 | 2018-03-13 | 桂林华诺威生物科技有限公司 | 一种医用透明质酸钠凝胶的制备方法 |
CN107936312A (zh) * | 2017-11-29 | 2018-04-20 | 桂林华诺威生物科技有限公司 | 交联透明质酸钠生物膜的制备方法 |
WO2019121688A1 (en) | 2017-12-22 | 2019-06-27 | Nestlé Skin Health Sa | Injectable gel product |
PL3731808T3 (pl) * | 2017-12-29 | 2024-03-18 | Matex Lab S.P.A. | Sposób przygotowania wypełniacza na bazie kwasu hialuronowego obejmujący etap zobojętnienia |
CN111918639A (zh) * | 2017-12-29 | 2020-11-10 | 马特克斯拉比有限公司 | 使用特定交联剂制备具有透明质酸基的填充物的方法 |
KR102392812B1 (ko) * | 2018-07-06 | 2022-04-29 | 주식회사 엘지화학 | 높은 점탄성 및 응집성을 동시에 갖는 히알루론산 필러 |
CN108774330B (zh) * | 2018-08-30 | 2020-11-10 | 华熙生物科技股份有限公司 | 一种交联透明质酸凝胶的制备方法及所得产品和应用 |
EP3659632A1 (en) * | 2018-11-29 | 2020-06-03 | Nestlé Skin Health SA | Post-crosslinking partial degradation of amide crosslinked hydrogels |
CN109810264B (zh) * | 2018-12-03 | 2021-08-06 | 浙江景嘉医疗科技有限公司 | 一种低改性的高粘度透明质酸凝胶及其制备方法和应用 |
CA3122116C (en) * | 2018-12-20 | 2023-07-18 | Lg Chem, Ltd. | Filler having excellent filler properties comprising hyaluronic acid hydrogel |
CN111234271B (zh) * | 2019-08-29 | 2021-10-01 | 上海其胜生物制剂有限公司 | 一种引导交联透明质酸钠凝胶结构重排的方法 |
CN110818918B (zh) * | 2019-11-28 | 2022-03-29 | 华熙生物科技股份有限公司 | 一种多维复合交联透明质酸凝胶的制备方法及所得产品和应用 |
CN111019163B (zh) * | 2019-12-10 | 2022-09-06 | 华熙生物科技股份有限公司 | 一种三偏磷酸钠交联透明质酸粉末的制备方法及所得产品和应用 |
CN110964215B (zh) * | 2019-12-26 | 2022-03-29 | 华熙生物科技股份有限公司 | 一种注射用左旋聚乳酸和交联透明质酸复合凝胶的制备方法及所得产品 |
FR3105922B1 (fr) | 2020-01-08 | 2022-12-02 | Le Rouge Francais | Composition cosmétique pour le traitement des lèvres sous forme de solide compact contenant au moins un agent probiotique et au moins un composé choisi parmi l'acide hyaluronique et ses dérivés. |
CN113278170B (zh) * | 2021-06-15 | 2021-11-16 | 苏州大学 | 一种化学交联透明质酸水凝胶及其制备方法与应用 |
CN115558170A (zh) * | 2021-10-15 | 2023-01-03 | 北京华熙海御科技有限公司 | 水凝胶固体以及使用水凝胶固体评估纸巾水活度的方法 |
CN115838478B (zh) * | 2022-01-14 | 2023-09-05 | 天津键凯科技有限公司 | 一种透明质酸衍生物或其盐及其制备方法和应用 |
CN115572396B (zh) * | 2022-12-08 | 2023-03-24 | 四川兴泰普乐医疗科技有限公司 | 一种可梯度降解的透明质酸钠凝胶及其制备方法 |
CN116284886A (zh) * | 2023-04-10 | 2023-06-23 | 上海其胜生物制剂有限公司 | 多重交联的凝胶体系及其产品、制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318695B2 (en) * | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
CN102952275A (zh) * | 2011-08-19 | 2013-03-06 | 上海建华精细生物制品有限公司 | 一种双相技术运用的透明质酸凝胶及其制备方法 |
CN102836465B (zh) * | 2012-08-30 | 2014-06-04 | 浙江星月生物科技股份有限公司 | 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用 |
CN104086788B (zh) * | 2014-07-17 | 2016-08-17 | 华熙福瑞达生物医药有限公司 | 一种注射用修饰透明质酸钠凝胶 |
CN104194008B (zh) * | 2014-08-08 | 2017-09-15 | 陕西佰傲再生医学有限公司 | 一种交联透明质酸凝胶微粒及其制备方法 |
-
2016
- 2016-12-12 CN CN201611138968.6A patent/CN106589424B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106589424A (zh) | 2017-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106589424B (zh) | 一种注射用交联透明质酸凝胶及其制备方法 | |
JP6106686B2 (ja) | 水不溶性ゲル組成物およびその製造方法 | |
CN102229705B (zh) | 一种胶原蛋白温敏型水凝胶及其制备方法 | |
KR102238406B1 (ko) | 항산화제를 포함하는 피부 충전제 조성물 | |
CN110964215B (zh) | 一种注射用左旋聚乳酸和交联透明质酸复合凝胶的制备方法及所得产品 | |
CN104086788B (zh) | 一种注射用修饰透明质酸钠凝胶 | |
CN102863631B (zh) | 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法 | |
US11866556B2 (en) | Process for efficient cross-linking of hyaluronic acid | |
CN107522881B (zh) | 制备单相修饰透明质酸钠凝胶的方法 | |
CN106397846A (zh) | 一种交联透明质酸钠及其制备方法与应用 | |
CN113429589B (zh) | 甘草酸基pH敏感型缓释水凝胶材料及其制备方法与应用 | |
CN110812270B (zh) | 一种用于水光注射的透明质酸凝胶组合物及其制备方法 | |
TW201620496A (zh) | 具有改良抗性之多糖軟組織充填劑 | |
CN102643498A (zh) | 一种含动植物纤维和无机纳米粒子的吸水凝胶的制备方法 | |
CN110279888A (zh) | 一种注射用琼脂糖凝胶剂及其制备方法 | |
JP6561133B2 (ja) | 生体適合性組成物及びこの製造方法 | |
CN111068114B (zh) | 一种含甘露醇的注射用修饰透明质酸钠凝胶的制备方法 | |
CN111686664B (zh) | 一种注射用乳化交联透明质酸钠凝胶微球及制备方法 | |
CN109010912B (zh) | 一种改性的玻尿酸可注射填充材料及其制备方法 | |
KR102417671B1 (ko) | 자가가교 시스템을 가지는 히알루론산 기반 연조직 충전 조성물 및 이의 제조방법 | |
CN114712530B (zh) | 提高重组胶原蛋白填充剂稳定性的湿热灭菌方法 | |
CN108578770A (zh) | 一种具有长效功能的注射医疗美容悬浮液及制备方法 | |
CN111019163B (zh) | 一种三偏磷酸钠交联透明质酸粉末的制备方法及所得产品和应用 | |
CN117618672A (zh) | 一种注射用琼脂糖凝胶剂的制备方法 | |
CN117511003A (zh) | 高黏弹性玻璃酸钠水凝胶原料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 250101 678 Tianchen street, hi tech Development Zone, Ji'nan, Shandong Applicant after: BLOOMAGE BIOTECH Co.,Ltd. Applicant after: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Address before: 250101 678 Tianchen street, hi tech Development Zone, Ji'nan, Shandong Applicant before: BLOOMAGE FREDA BIOPHARM Co.,Ltd. Applicant before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210922 Address after: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee after: BLOOMAGE BIOTECH Co.,Ltd. Patentee after: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Patentee after: Huaxi Biotechnology (Tianjin) Co.,Ltd. Address before: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee before: BLOOMAGE BIOTECH Co.,Ltd. Patentee before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230707 Address after: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee after: BLOOMAGE BIOTECH Co.,Ltd. Patentee after: Huaxi Biotechnology (Tianjin) Co.,Ltd. Address before: Tianchen Avenue, Ji'nan hi tech Development Zone of Shandong Province, No. 678 250101 Patentee before: BLOOMAGE BIOTECH Co.,Ltd. Patentee before: SHANDONG BLOOMAGE HYINC BIOPHARM Corp.,Ltd. Patentee before: Huaxi Biotechnology (Tianjin) Co.,Ltd. |
|
TR01 | Transfer of patent right |